Citigroup
AURA icon

Citigroup’s Aura Biosciences AURA Stock Holding History

Citigroup’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.5K Sell
12,482
-22,409
-64% -$129K ﹤0.01% 4346
2025
Q4 		$190K Buy
34,891
+29,457
+542% +$175K ﹤0.01% 4026
2025
Q3 		$33.6K Sell
5,434
-8,575
-61% -$56.1K ﹤0.01% 4619
2025
Q2 		$87.7K Sell
14,009
-18,856
-57% -$110K ﹤0.01% 4467
2025
Q1 		$193K Sell
32,865
-2,876
-8% -$21.8K ﹤0.01% 4227
2024
Q4 		$294K Buy
35,741
+1,841
+5% +$17.3K ﹤0.01% 4161
2024
Q3 		$302K Buy
33,900
+23,488
+226% +$201K ﹤0.01% 4075
2024
Q2 		$78.7K Buy
10,412
+3,727
+56% +$27.3K ﹤0.01% 4331
2024
Q1 		$52.5K Buy
6,685
+2,669
+66% +$22.1K ﹤0.01% 4595
2023
Q4 		$35.6K Sell
4,016
-102,410
-96% -$867K ﹤0.01% 4698
2023
Q3 		$955K Sell
106,426
-42,070
-28% -$453K ﹤0.01% 2555
2023
Q2 		$1.83M Sell
148,496
-367,546
-71% -$3.93M ﹤0.01% 2302
2023
Q1 		$4.79M Buy
516,042
+370,338
+254% +$3.85M ﹤0.01% 1530
2022
Q4 		$1.53M Sell
145,704
-4,036
-3% -$51.4K ﹤0.01% 2252
2022
Q3 		$2.71M Buy
149,740
+26,552
+22% +$402K ﹤0.01% 1929
2022
Q2 		$1.75M Buy
123,188
+122,969
+56,150% +$2.03M ﹤0.01% 2206
2022
Q1 		$5K Sell
219
-1,586
-88% -$30.2K ﹤0.01% 5794
2021
Q4 		$31K Buy
+1,805
New +$32.3K ﹤0.01% 5250

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citigroup's AURA Position: Q1 2026 in Review

Citigroup reduced its Aura Biosciences (AURA) stake by 64% in Q1 2026, selling an estimated $129K and leaving 12,482 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4346.

Citigroup first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.79M in Q1 2023. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Citigroup held 12,482 shares of Aura Biosciences worth $83.5K as of Q1 2026.
  • Citigroup sold 22,409 Aura Biosciences shares in Q1 2026, an estimated $129K.
  • Aura Biosciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4346 holding.
  • Citigroup first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Citigroup's Aura Biosciences position peaked at $4.79M in Q1 2023.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.